OSR Health Shareholders Greenlight 150% Expansion of Authorized Shares to 250 Million

summarizeSummary

OSR Health shareholders approved a 150% increase in authorized shares to 250 million, creating massive potential dilution headroom. The vote also re-elected all directors and ratified the auditor.

check_boxKey Events · Corporate Governance and Compliance · OSRH

• Authorized Shares Surge to 250M

  Shareholders approved an increase in authorized common stock from 100 million to 250 million shares, a 150% jump. With 35.1 million shares outstanding, the company now has headroom to issue up to 214.9 million additional shares.

• Potential Dilution Exceeds 600%

  If all newly authorized shares were issued, existing shareholders would face dilution of over 600% (214.9M new shares / 35.1M outstanding). The actual impact depends on future issuance decisions.

• Directors Re-elected, Auditor Ratified

  All seven director nominees were re-elected, and the appointment of the independent auditor was ratified with over 20 million votes in favor.

• Executive Compensation Approved

  The advisory vote on executive compensation passed with 15.1 million votes for, 83,113 against, and 161,533 abstentions.

auto_awesomeAnalysis · OSRH · Industrial Applications And Services

At the annual meeting, shareholders approved a massive increase in authorized common stock from 100 million to 250 million shares. With 35.1 million shares outstanding, this creates headroom for up to 214.9 million additional shares — potential dilution of over 600% if fully issued. The vote follows a proxy filing in July and comes amid a series of capital-raising and restructuring moves, including a recent name change and charter revival. While the authorization does not immediately dilute existing holders, it arms management with the flexibility to issue substantial equity for acquisitions, financing, or other purposes, which could significantly impact the stock.